Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial biofilm structural lattice is a complex, three-dimensional network composed primarily of extracellular DNA (eDNA), proteins (including DNABII family members), and exopolysaccharides. This matrix provides mechanical stability, protects bacteria from environmental stressors, and facilitates cell-to-cell communication within the biofilm. Targeting components of this lattice is a promising strategy for disrupting biofilms and enhancing the efficacy of antimicrobial treatments.
Enzymatic degradation of eDNA; Disruption of protein-DNA interactions; Degradation of polysaccharides; Chelation of divalent cations
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Biofilm Structural Lattice (N/A).